Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 3;13(6):997-1003.
doi: 10.1080/15548627.2017.1309485. Epub 2017 Apr 25.

Autophagy and kidney inflammation

Affiliations
Review

Autophagy and kidney inflammation

Tomonori Kimura et al. Autophagy. .

Abstract

Inflammation plays a pivotal role in pathophysiological processes of kidney diseases. Macroautophagy/autophagy plays multiple roles in inflammatory responses, and the regulation of inflammation by autophagy has great potential as a treatment for damaged kidneys. A growing body of evidence suggests autophagy protects kidney from versatile kidney inflammatory insults, including those that are acute, chronic, metabolic, and aging-related. It is noteworthy that, in kidney, mitophagy is active, and damaged lysosomes are removed by autophagy. In this mode, autophagy suppresses inflammation to protect the kidney. Systemic inflammation also affects the kidney via pro-inflammatory cytokines and infiltration of inflammatory cells, and autophagy also has a regulatory role in systemic inflammation. This review focuses on the roles of autophagy in kidney diseases and aging through inflammation, and discusses the potential usage of autophagy as an inflammatory modulator for the treatment of kidney diseases.

Keywords: acute kidney injury; aging; autoimmune disease; autophagy; chronic kidney disease; cytokine; diabetes; end-stage kidney disease; inflammation; innate immunity; kidney; lysosome; mitochondria; sepsis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Autophagy and kidney inflammation. Autophagy suppresses excessive inflammatory responses, such as inflammasome activation and type I interferon responses, through the clearance of damage-associated molecular patterns (DAMPs) and damaged mitochondria (mitophagy). Autophagy of damaged lysosomes (lysophagy) also prevents activation of inflammatory responses. Excessive inflammatory responses are the fundamental basis for most kidney diseases, including acute kidney injury, chronic kidney disease, diabetic nephropathy, and the aging process, as well as systemic inflammation-associated kidney injury, which is often seen in sepsis patients. Thus, autophagy protects kidney from these insults via suppression of inflammatory responses. IRF3, interferon regulatory factor 3.

References

    1. Anders HJ, Schaefer L. Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol 2014; 25:1387-400; PMID: 24762401; https://doi.org/10.1681/ASN.2014010117 - DOI - PMC - PubMed
    1. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 2011; 27:107-32; PMID: 21801009; https://doi.org/10.1146/annurev-cellbio-092910-154005 - DOI - PubMed
    1. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147:728-41; PMID: 22078875; https://doi.org/10.1016/j.cell.2011.10.026 - DOI - PubMed
    1. Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity 2013; 39:211-27; PMID: 23973220; https://doi.org/10.1016/j.immuni.2013.07.017 - DOI - PubMed
    1. Deretic V, Kimura T, Timmins G, Moseley P, Chauhan S, Mandell M. Immunologic manifestations of autophagy. J Clin Invest 2015; 125:75-84; PMID: 25654553; https://doi.org/10.1172/JCI73945 - DOI - PMC - PubMed

LinkOut - more resources